Jeff Yass’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Other funds holding CGON
Jeff Yass's CGON Position: Q3 2026 in Review
Jeff Yass increased its CG Oncology (CGON) stake by 1,537% in Q3 2026, buying an estimated $17.7M and bringing the position to 256,192 shares worth $18.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2567.
Jeff Yass first reported a position in CGON in Q1 2024 and has held it in 8 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q3 2026.
- Jeff Yass held 256,192 shares of CG Oncology worth $18.2M as of Q3 2026.
- Jeff Yass bought 240,539 CG Oncology shares in Q3 2026, an estimated $17.7M.
- CG Oncology made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #2567 holding.
- Jeff Yass first reported a position in CG Oncology in Q1 2024 and has held it in 8 quarters since.
- 233 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.